UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): June 9, 2011
Integra LifeSciences Holdings Corporation
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
|
| Delaware
|
|
000-26244
|
|
510317849 |
|
|
|
|
|
|
| (State or other jurisdiction
|
|
(Commission
|
|
(I.R.S. Employer |
| of incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
|
| 311 Enterprise Drive, Plainsboro, New Jersey
|
|
08536 |
|
|
|
|
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: 609-275-0500
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
TABLE OF CONTENTS
Item 8.01 Other Events.
Notes Offering
On June 9, 2011, Integra LifeSciences Holdings Corporation issued a press release pursuant to
Rule 135c under the Securities Act of 1933, as amended, regarding its proposed issuance of up to
$230.0 million in aggregate principal amount of convertible senior notes due 2016 (“the Notes
Offering”) through a private placement to qualified institutional buyers in the United States
pursuant to Rule 144A under the Securities Act of 1933.
In accordance with Rule 135c(d) under the Securities Act, a copy of the press release is
attached hereto as Exhibit 99.1.
Item 9.01 Financial Statement and Exhibits.
| |
|
|
|
|
|
| |
99.1 |
|
Press Release of Integra LifeSciences Holdings Corporation, dated
June 9, 2011 regarding the Notes Offering. |